Getalong Enterprise Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of Getalong Enterprise Ltd is ₹ 5.1 as of 16 Mar 15:30 . The P/E Ratio of Getalong Enterprise Ltd is 0 as of March 2021 .The P/E Ratio of Sheel Biotech Ltd is 0 as of March 2021 . The Market Cap of Getalong Enterprise Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Sheel Biotech Ltd is ₹ 0 crore as of March 2021 . The Dividend Payout of Getalong Enterprise Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About Getalong Enterprise Ltd

Getalong Enterprise Limited was incorporated as Getalong Enterrprise Private Limited' on 29 July, 2020.
Thereafter, pursuant to the conversion to a Public Limited Company, the name of the Company was changed to Getalong Enterprise Limited' and a fresh Certificate of Incorporation dated April 12, 2021 was issued to the Company by the Registrar of Companies, Mumbai.
The Company is a One Stop for Tax Solutions & Allied Services. Prior to this, Company has a diversified product portfolio mainly operating in three key segments which includes - Textiles, Gold Bullion and Female Care Products.
Under the Textiles division, the company is engaged in to exports of readymade garments to African continent and Middle East countries.
Under the Gold Bullion division, the Company purchases old gold / ornaments from retail customers / vendors.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Getalong Enterprise Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Getalong Enterprise Ltd or Sheel Biotech Ltd?

Market cap of Getalong Enterprise Ltd is 10 Cr while Market cap of Sheel Biotech Ltd is 111 Cr

What are the key factors driving the stock performance of Getalong Enterprise Ltd and Sheel Biotech Ltd?

The stock performance of Getalong Enterprise Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Getalong Enterprise Ltd and Sheel Biotech Ltd?

As of March 16, 2026, the Getalong Enterprise Ltd stock price is INR ₹5.13. On the other hand, Sheel Biotech Ltd stock price is INR ₹54.8.

How do dividend payouts of Getalong Enterprise Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Getalong Enterprise Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.